FATE: Fate Therapeutics Inc
FATE exchange rate has changed by -3.62% for today. During the day, the instrument was traded at a low of 1.26 and at a high of 1.37.
Follow Fate Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
FATE News
- Baird reiterates Fate Therapeutics stock rating on trial progress
- Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates
- Fate Therapeutics earnings beat, revenue topped estimates
- Fate Therapeutics reports positive lupus treatment data at ASH meeting
- Fate Therapeutics earnings beat by $0.03, revenue topped estimates
- Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates
- Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
- 3 Cancer-Focused Stocks Showing Strong Pipeline Progress
- Incyte (INCY) Tops Q3 Earnings and Revenue Estimates
- Fate Therapeutics at Cantor Global Healthcare Conference: CAR T Cell Advances
- Leerink Partners lowers Fate Therapeutics stock price target to $7 on iPSC CAR’iT pivot
- Fate Therapeutics: Recent Update Met With Selling, But Positives Exist
- Wells Fargo lowers Fate Therapeutics stock price target to $2.50 on cost cuts
- Fate Therapeutics earnings beat by $0.05, revenue topped estimates
- Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates
- Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates
- Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Misses Revenue Estimates
- H.C. Wainwright maintains Neutral rating on Fate Therapeutics stock at $5
- Needham maintains hold on Fate Therapeutics stock despite lupus data
- Fate Therapeutics price target lowered to $2.20 by BofA on SLE data
- Fate’s FT819 shows promising results in lupus patients
- Guggenheim maintains buy rating on Neurocrine Bio stock amid growth prospects
- RBC Capital maintains outperform rating for Neurocrine Bio stock
Frequently Asked Questions
What is FATE stock price today?
Fate Therapeutics Inc stock is priced at 1.33 today. It trades within 1.26 - 1.37, yesterday's close was 1.38, and trading volume reached 1752. The live price chart of FATE shows these updates.
Does Fate Therapeutics Inc stock pay dividends?
Fate Therapeutics Inc is currently valued at 1.33. Dividend policy depends on the company, while investors also watch 68.35% and USD. View the chart live to track FATE movements.
How to buy FATE stock?
You can buy Fate Therapeutics Inc shares at the current price of 1.33. Orders are usually placed near 1.33 or 1.63, while 1752 and -0.75% show market activity. Follow FATE updates on the live chart today.
How to invest into FATE stock?
Investing in Fate Therapeutics Inc involves considering the yearly range 0.66 - 1.94 and current price 1.33. Many compare -8.28% and 7.26% before placing orders at 1.33 or 1.63. Explore the FATE price chart live with daily changes.
What are Fate Therapeutics Inc stock highest prices?
The highest price of Fate Therapeutics Inc in the past year was 1.94. Within 0.66 - 1.94, the stock fluctuated notably, and comparing with 1.38 helps spot resistance levels. Track Fate Therapeutics Inc performance using the live chart.
What are Fate Therapeutics Inc stock lowest prices?
The lowest price of Fate Therapeutics Inc (FATE) over the year was 0.66. Comparing it with the current 1.33 and 0.66 - 1.94 shows potential long-term entry points. Watch FATE moves on the chart live for more details.
When did FATE stock split?
Fate Therapeutics Inc has gone through stock splits historically. These changes are visible in , 1.38, and 68.35% after corporate actions.
- Previous Close
- 1.38
- Open
- 1.34
- Bid
- 1.33
- Ask
- 1.63
- Low
- 1.26
- High
- 1.37
- Volume
- 1.752 K
- Daily Change
- -3.62%
- Month Change
- -8.28%
- 6 Months Change
- 7.26%
- Year Change
- 68.35%